title: Different processing of meningeal and cutaneous pain information in the spinal trigeminal nucleus caudalis.
abstract: Introduction Within superficial trigeminal nucleus caudalis (Sp5C) (laminae I/II), meningeal primary afferents project exclusively to lamina I, whereas nociceptive cutaneous ones distribute in both lamina I and outer lamina II. Whether such a relative absence of meningeal inputs to lamina II represents a fundamental difference from cutaneous pathways in the central processing of sensory information is still unknown. Methods We recorded extracellular field potentials in the superficial Sp5C of anesthetised rats evoked by electrically stimulating the dura mater, to selectively assess the synaptic transmission between meningeal primary afferents and second-order Sp5C neurons, the first synapse in trigeminovascular pathways. We tested the effect of systemic morphine and local glycinergic and GABAAergic disinhibition. Results Meningeal stimulation evokes two negative field potentials in superficial Sp5C. The conduction velocities of the activated primary afferents are within the Aδ- and C-fibre ranges. Systemic morphine specifically suppresses meningeal C-fibre-evoked field potentials, and this effect is reversed by systemic naloxone. Segmental glycinergic or GABAAergic disinhibition strongly potentiates meningeal C-fibre-evoked field potentials but not Aδ-fibre ones. Interestingly, the same segmental disinhibition conversely potentiates cutaneous Aδ-fibre-evoked field potentials and suppresses C-fibre ones. Conclusion These findings reveal that the different anatomical organization of meningeal and cutaneous inputs into superficial Sp5C is associated with a different central processing of meningeal and cutaneous pain information within Sp5C. Moreover, they suggest that the potentiation upon local disinhibition of the first synapse in trigeminovascular pathways may contribute to the generation of headache pain.
authors.affiliation: 1 Clermont University, University of Auvergne, Clermont-Ferrand, France.|2 Clermont-Ferrand University Hospital, Department of Odontology, Clermont-Ferrand, France.
authors.forename: Céline
authors.initials: C
authors.lastname: Melin
authors.affiliation: 1 Clermont University, University of Auvergne, Clermont-Ferrand, France.
authors.forename: Florian
authors.initials: F
authors.lastname: Jacquot
authors.affiliation: 1 Clermont University, University of Auvergne, Clermont-Ferrand, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Vitello
authors.affiliation: 1 Clermont University, University of Auvergne, Clermont-Ferrand, France.|2 Clermont-Ferrand University Hospital, Department of Odontology, Clermont-Ferrand, France.
authors.forename: Radhouane
authors.initials: R
authors.lastname: Dallel
authors.affiliation: 1 Clermont University, University of Auvergne, Clermont-Ferrand, France.
authors.forename: Alain
authors.initials: A
authors.lastname: Artola
mesh_terms: D000344:Afferent Pathways / Q000166:cytology; D000818:Animals; D006261:Headache / Q000503:physiopathology; D008297:Male; D008578:Meninges / Q000166:cytology*; D009475:Neurons, Afferent / Q000166:cytology; D010146:Pain; D051381:Rats; D017207:Rats, Sprague-Dawley; D012867:Skin / Q000294:innervation; D014275:Trigeminal Caudal Nucleus / Q000166:cytology*
keywords: GABA; Migraine; glycine; morphine; rat; synaptic inhibition